Page last updated: 2024-08-21

medroxyprogesterone and Coronary Artery Disease

medroxyprogesterone has been researched along with Coronary Artery Disease in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Manson, JE; Robins, JM; Shufelt, CL	1
Bergmann, SR; Bokhari, S	1
Barrett-Connor, E; Bibbins-Domingo, K; Grady, D; Hulley, SB; Lin, F; Shlipak, MG; Vittinghoff, E	1
Kremastinos, DT; Kyriakides, ZS; Sbarouni, E	1
Christian, RC; Edwards, WD; Fitzpatrick, LA; Harrington, S; Oberg, AL	1

Trials

1 trial(s) available for medroxyprogesterone and Coronary Artery Disease

Article	Year
The effect of hormone replacement therapy and simvastatin on plasma homocysteine. Journal of women's health (2002), 2005, Volume: 14, Issue:2 Topics: Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Medroxyprogesterone; Middle Aged; Simvastatin; Time Factors; Treatment Outcome	2005

Article

Year

The effect of hormone replacement therapy and simvastatin on plasma homocysteine.

Journal of women's health (2002), 2005, Volume: 14, Issue:2

Topics: Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Medroxyprogesterone; Middle Aged; Simvastatin; Time Factors; Treatment Outcome

2005

Other Studies

4 other study(ies) available for medroxyprogesterone and Coronary Artery Disease

Article	Year
The Potential for Postrandomization Confounding in Randomized Clinical Trials. JAMA, 2016, Jun-07, Volume: 315, Issue:21 Topics: Cholesterol, LDL; Confounding Factors, Epidemiologic; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Medroxyprogesterone; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2016
The effect of estrogen compared to estrogen plus progesterone on the exercise electrocardiogram. Journal of the American College of Cardiology, 2002, Sep-18, Volume: 40, Issue:6 Topics: Aged; Coronary Artery Disease; Coronary Circulation; Drug Therapy, Combination; Electrocardiography; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Exercise Test; False Positive Reactions; Female; Humans; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Retrospective Studies; Sensitivity and Specificity	2002
Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease. The American journal of cardiology, 2005, Jan-15, Volume: 95, Issue:2 Topics: Aged; California; Coronary Artery Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Heart Failure; Humans; Medroxyprogesterone; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis	2005
Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Arteries; Calcium; Coronary Artery Disease; Coronary Vessels; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged	2002